Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
September 11, 2018
Patent Application Number
15328235
Date Filed
July 23, 2015
Patent Citations Received
Patent Primary Examiner
Patent abstract
Disclosed are methods for treating a myelodysplastic syndrome (MDS) in a subject that involves administering to the subject a therapeutically effective amount of a protein phosphatase 2A (PP2A) inhibitor.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
